Site icon OncologyTube

Evolving Treatment Landscape Of nmCRPC

Nicholas Vogelzang, MD, FASCO, FACP, Medical Oncologist, Comprehensive Cancer Centers of Nevada, Discusses Combining Checkpoint Inhibitors In mCRPC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019.

http://obroncology.com

Advertisement
Exit mobile version